載入...

Treatment of experimental autoimmune uveoretinitis with peroxisome proliferator-activated receptor α agonist fenofibrate

PURPOSE: The peroxisome proliferator-activated receptor α (PPARα) agonist has been approved for treating hypercholesterolemia and lipid abnormalities. Researchers have recently discovered that an anti-inflammatory effect of PPAR agonist may have the potential to treat autoimmune disease. This study...

全面介紹

Na minha lista:
書目詳細資料
發表在:Mol Vis
Main Authors: Osada, Miho, Sakai, Tsutomu, Kuroyanagi, Kana, Kohno, Hideo, Tsuneoka, Hiroshi
格式: Artigo
語言:Inglês
出版: Molecular Vision 2014
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4225135/
https://ncbi.nlm.nih.gov/pubmed/25489225
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!